Redburn Partners Upgrades Monster Beverage to Buy, Announces $120 Price Target
Redburn Partners analyst Charlie Higgs upgrades Monster Beverage (NASDAQ:MNST) from Neutral to Buy and announces $120 price target.
RBC Capital Upgrades Enerflex to Outperform, Raises Price Target to C$16
RBC Capital analyst Keith Mackey upgrades Enerflex (TSX:EFX) from Sector Perform to Outperform and raises the price target from C$12 to C$16.
UBS Upgrades Emerson Electric to Buy, Lowers Price Target to $97
UBS analyst Chris Snyder upgrades Emerson Electric (NYSE:EMR) from Neutral to Buy and lowers the price target from $100 to $97.
Morgan Stanley Upgrades Ternium to Overweight, Raises Price Target to $52
Morgan Stanley analyst Carlos De Alba upgrades Ternium (NYSE:TX) from Equal-Weight to Overweight and raises the price target from $34 to $52.
JP Morgan Upgrades Meritage Homes to Overweight, Announces $129 Price Target
JP Morgan analyst Michael Rehaut upgrades Meritage Homes (NYSE:MTH) from Neutral to Overweight and announces $129 price target.
Baird Upgrades REV Group to Outperform, Announces $16 Price Target
Baird analyst Mircea Dobre upgrades REV Group (NYSE:REVG) from Neutral to Outperform and announces $16 price target.
Analyst Upgrades This Radiology Stock, Expects Promising 2023 Ahead
Raymond James upgraded Radnet Inc (NASDAQ:RDNT) from Market Perform to Outperform and a price target of $30 following 4Q22 results that came in…
Analyst Upgrades This Stock And Doubles Price Target On Encouraging Ibsrela Story
After the market close Thursday, Ardelyx Inc (NASDAQ:ARDX) reported Q4 FY22 Ibsrela sales of $8.7 million and $15.6 million for FY22. The…
Bilibili Likely To Gain From New Game Launches, Auto, 3C And Recovery In Performance Based Ads, Analysts Say
Citigroup analyst Brian Gong upgrades Bilibili Inc (NASDAQ: BILI) from
Why This Procter & Gamble Analyst Is Turning Bullish After Shares Down For Past Year
Shares of Procter & Gamble Co (NYSE: PG) have lost more than 7% year to date.
The company is poised to return to compounding earnings ahead, according to JPMorgan.